Delivery Order 75F40121D00004-75F40122F19002

Award Date 3/14/22
Potential Completion Date 7/18/23
Potential Value $150K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Burlington, NC, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This delivery order, awarded by the Department of Health and Human Services' Food and Drug Administration, is for $20,069.53 to provide COVID-19 testing for FDA employees and contractors. The prime contractor is Laboratory Corporation of America of Burlington, North Carolina, a subsidiary of Laboratory Corporation of America Holdings. The firm fixed price order is for coronavirus disease 2019 testing services to support the FDA's mission during the ongoing pandemic. No set-aside designation...
The Department of Health and Human Services Food and Drug Administration awarded a $190,775 firm fixed price delivery order contract to Laboratory Corporation of America Holdings for COVID-19 testing for 2,500 ORA employees. As the parent company of Laboratory Corporation of America, the prime contractor awarded, Laboratory Corporation of America will provide coronavirus testing to support FDA inspectional activities. No set-aside designation was used for this contract awarded on September 15,...
The Department of Health and Human Services Food and Drug Administration awarded a $40,291.68 firm fixed price delivery order against the Medical Laboratory Testing and Analysis Services GSA Schedule to Laboratory Corporation of America. The contract calls for Laboratory Corporation of America to provide COVID-19 testing for FDA employees and contractors in Silver Spring, Maryland through July 2027. As the largest commercial clinical laboratory network in the United States, Laboratory...
The Department of Health and Human Services Food and Drug Administration awarded a $15,262 firm fixed price delivery order contract to Laboratory Corporation of America Holdings for COVID-19 testing for 200 personnel with the Centers for Tobacco Products. Under the contract, Laboratory Corporation of America will provide COVID-19 testing services to support FDA inspectional activities. The contract has a period of performance through September 14, 2021 and was awarded on September 15, 2020...
The Department of Health and Human Services Office of the Assistant Secretary for Administration awarded Laboratory Corporation of America a $12.99 million firm fixed-price purchase order to provide COVID-19 laboratory testing services from May 6, 2020 through July 31, 2020 under a ratification action. The purpose of the purchase order was to ratify laboratory testing performed for HHS under Contract BTS 1.0 from the initial period of need. As the prime contractor, Laboratory Corporation of...
The Department of Health and Human Services Office of the Assistant Secretary for Administration awarded Laboratory Corporation of America a $4.59 million firm fixed price purchase order to provide COVID-19 laboratory testing services from March 18, 2020 to August 14, 2020. The purpose of this ratification was to cover services already provided from March 18 to May 5, 2020 totaling $4.59 million. Laboratory Corporation of America, as the prime contractor, will perform the testing at its...
This is a $91,693,500.00 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (Labcorp) for COVID-19 laboratory testing services. The contract has an ultimate completion date of April 22, 2025 and is not set aside for small businesses. Labcorp, a leading global life sciences company, will provide comprehensive diagnostic testing and medical laboratory services to support various federal government healthcare...
This federal contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Laboratory Corporation of America Holdings, a global life sciences company. The $169,142.60 firm-fixed-price purchase order is to support the supply of COVID-19 at-home test kits for fiscal year 2020. The contract does not have a set-aside designation. Laboratory Corporation of America Holdings has previously provided serology testing...
This is a $5,273,743 firm fixed-price definitive contract awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings. The contract does not have a set-aside designation. Under this contract, Labcorp will provide a range of laboratory testing and analytical services to support the federal government, including stability testing, potency and safety assays for drug...
This is a $47,916,380.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (Labcorp) for serology testing services. The contract has a firm fixed price pricing type and a period of performance through March 5, 2022. The original solicitation was a pre-solicitation for laboratory testing of blood specimens to determine SARS-CoV-2 seroprevalence across the United States. The contract supports the CDC's public health initiatives...
  • 75F40121D00004
    Indefinite Delivery Contract
  • 75F40121D00004-75F40122F19002
    Delivery Order

This $149,949.15 firm fixed price delivery order was awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Laboratory Corporation of America for COVID-19 testing services for FDA employees and contractors. The contract has a period of performance through July 18, 2023 and no set-aside designation was used. As the largest commercial clinical laboratory network in the world, Laboratory Corporation of America will leverage its extensive experience and infrastructure to provide FDA with critical COVID-19 testing to support the agency's important work ensuring the safety of medical products during the ongoing pandemic.

Generated 1/3/24, 12:41 PM